Comment diagnostiquer une intoxication aux thiosulfates ?
Le diagnostic repose sur l'historique médical et des tests sanguins pour mesurer les niveaux de thiosulfate.
IntoxicationThiosulfates
#2
Quels tests sont utilisés pour évaluer les thiosulfates ?
Des analyses de sang et d'urine peuvent être effectuées pour détecter les thiosulfates.
Tests de laboratoireThiosulfates
#3
Quels symptômes indiquent une intoxication aux thiosulfates ?
Les symptômes incluent des nausées, des vomissements, et des troubles respiratoires.
SymptômesIntoxication
#4
Y a-t-il des marqueurs biologiques pour les thiosulfates ?
Oui, des niveaux élevés de thiosulfate dans le sang peuvent indiquer une intoxication.
Marqueurs biologiquesThiosulfates
#5
Comment différencier les thiosulfates d'autres composés ?
Des tests chimiques spécifiques peuvent identifier les thiosulfates parmi d'autres composés.
Composés chimiquesThiosulfates
Symptômes
5
#1
Quels sont les symptômes courants d'une intoxication ?
Les symptômes incluent des maux de tête, des nausées, et des troubles neurologiques.
SymptômesIntoxication
#2
Les thiosulfates provoquent-ils des effets secondaires ?
Oui, des effets secondaires comme des démangeaisons ou des éruptions cutanées peuvent survenir.
Effets secondairesThiosulfates
#3
Comment les thiosulfates affectent-ils le système respiratoire ?
Ils peuvent provoquer des difficultés respiratoires en cas d'intoxication sévère.
Système respiratoireIntoxication
#4
Y a-t-il des symptômes spécifiques chez les enfants ?
Les enfants peuvent présenter des symptômes plus graves, comme des convulsions.
EnfantsSymptômes
#5
Les thiosulfates affectent-ils le système digestif ?
Oui, ils peuvent causer des nausées, des vomissements et des douleurs abdominales.
Système digestifThiosulfates
Prévention
5
#1
Comment prévenir une intoxication aux thiosulfates ?
Évitez l'exposition à des sources connues de thiosulfates et suivez les consignes de sécurité.
PréventionThiosulfates
#2
Y a-t-il des mesures de sécurité en milieu professionnel ?
Oui, des équipements de protection individuelle doivent être utilisés lors de la manipulation.
Sécurité au travailThiosulfates
#3
Les thiosulfates peuvent-ils être évités dans certains aliments ?
Certains aliments peuvent contenir des thiosulfates; il est conseillé de les limiter si nécessaire.
AlimentationThiosulfates
#4
Quelles sont les recommandations pour les travailleurs exposés ?
Des formations sur les risques et l'utilisation d'équipements de protection sont essentielles.
TravailleursPrévention
#5
Les thiosulfates sont-ils réglementés ?
Oui, leur utilisation est souvent réglementée pour minimiser les risques d'intoxication.
RéglementationThiosulfates
Traitements
5
#1
Quel est le traitement principal pour l'intoxication aux thiosulfates ?
Le traitement consiste en l'administration de thiosulfate de sodium par voie intraveineuse.
TraitementThiosulfates
#2
Les thiosulfates sont-ils utilisés en médecine préventive ?
Oui, ils peuvent être utilisés pour prévenir les effets de certaines intoxications.
Médecine préventiveThiosulfates
#3
Y a-t-il des antidotes pour les thiosulfates ?
Le thiosulfate de sodium est souvent utilisé comme antidote pour les intoxications au cyanure.
AntidotesThiosulfates
#4
Comment administrer les thiosulfates en cas d'urgence ?
Ils doivent être administrés par un professionnel de santé, généralement par voie intraveineuse.
AdministrationThiosulfates
#5
Les thiosulfates sont-ils efficaces contre toutes les intoxications ?
Non, leur efficacité est spécifique à certaines intoxications, comme celle au cyanure.
EfficacitéIntoxication
Complications
5
#1
Quelles complications peuvent survenir après une intoxication ?
Des complications neurologiques et respiratoires peuvent survenir si non traitées.
ComplicationsIntoxication
#2
Les thiosulfates peuvent-ils causer des dommages permanents ?
Oui, une intoxication sévère peut entraîner des dommages neurologiques permanents.
DommagesThiosulfates
#3
Y a-t-il des risques de rechute après traitement ?
Oui, des rechutes peuvent se produire si l'exposition aux thiosulfates se poursuit.
RechuteIntoxication
#4
Comment surveiller les complications post-intoxication ?
Un suivi médical régulier est nécessaire pour détecter d'éventuelles complications.
Suivi médicalComplications
#5
Les complications sont-elles prévisibles ?
Certaines complications peuvent être prévisibles en fonction de la gravité de l'intoxication.
PrévisibilitéIntoxication
Facteurs de risque
5
#1
Quels sont les facteurs de risque d'intoxication aux thiosulfates ?
Les travailleurs dans l'industrie chimique et ceux manipulant des produits contenant des thiosulfates sont à risque.
Facteurs de risqueThiosulfates
#2
Les enfants sont-ils plus à risque d'intoxication ?
Oui, les enfants peuvent être plus vulnérables en raison de leur taille et de leur métabolisme.
EnfantsFacteurs de risque
#3
Y a-t-il des conditions médicales qui augmentent le risque ?
Certaines conditions, comme les maladies respiratoires, peuvent augmenter le risque d'intoxication.
Conditions médicalesThiosulfates
#4
Les personnes âgées sont-elles plus à risque ?
Oui, les personnes âgées peuvent avoir un métabolisme plus lent, augmentant le risque d'intoxication.
Personnes âgéesFacteurs de risque
#5
Comment évaluer le risque d'exposition aux thiosulfates ?
Une évaluation des conditions de travail et des habitudes de vie peut aider à évaluer le risque.
Évaluation des risquesThiosulfates
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thiosulfates : Questions médicales les plus fréquentes",
"headline": "Thiosulfates : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thiosulfates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-16",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thiosulfates"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sulfates",
"url": "https://questionsmedicales.fr/mesh/D013431",
"about": {
"@type": "MedicalCondition",
"name": "Sulfates",
"code": {
"@type": "MedicalCode",
"code": "D013431",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.875.800.800.850"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thiosulfate d'or et de sodium",
"alternateName": "Gold Sodium Thiosulfate",
"url": "https://questionsmedicales.fr/mesh/D012971",
"about": {
"@type": "MedicalCondition",
"name": "Thiosulfate d'or et de sodium",
"code": {
"@type": "MedicalCode",
"code": "D012971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.875.800.800.850.900.250"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Thiosulfates",
"alternateName": "Thiosulfates",
"code": {
"@type": "MedicalCode",
"code": "D013885",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Harry van Goor",
"url": "https://questionsmedicales.fr/author/Harry%20van%20Goor",
"affiliation": {
"@type": "Organization",
"name": "University Medical Center Groningen, Department of Pathology and Medical Biology the Netherlands. Electronic address: h.van.goor@umcg.nl."
}
},
{
"@type": "Person",
"name": "Matthew R Groves",
"url": "https://questionsmedicales.fr/author/Matthew%20R%20Groves",
"affiliation": {
"@type": "Organization",
"name": "Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands."
}
},
{
"@type": "Person",
"name": "Zayana M Al-Dahmani",
"url": "https://questionsmedicales.fr/author/Zayana%20M%20Al-Dahmani",
"affiliation": {
"@type": "Organization",
"name": "Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands."
}
},
{
"@type": "Person",
"name": "Jaap A Joles",
"url": "https://questionsmedicales.fr/author/Jaap%20A%20Joles",
"affiliation": {
"@type": "Organization",
"name": "University Medical Center Utrecht, Department of Nephrology and Hypertension, the Netherlands."
}
},
{
"@type": "Person",
"name": "Amalia M Dolga",
"url": "https://questionsmedicales.fr/author/Amalia%20M%20Dolga",
"affiliation": {
"@type": "Organization",
"name": "University of Groningen, Department of Pharmacy, Molecular Pharmacology, the Netherlands."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A case-control study of infections caused by",
"datePublished": "2022-07-28",
"url": "https://questionsmedicales.fr/article/35967868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcimb.2022.867347"
}
},
{
"@type": "ScholarlyArticle",
"name": "Errors in Surgery: A Case Control Study.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35946794",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/SLA.0000000000005664"
}
},
{
"@type": "ScholarlyArticle",
"name": "Iron status in women with infertility and controls: a case-control study.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37361544",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1173100"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35788952",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11695-022-06193-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diverticulitis Familiality: A Statewide Case-Control Study.",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37403933",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/XCS.0000000000000799"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Produits chimiques inorganiques",
"item": "https://questionsmedicales.fr/mesh/D007287"
},
{
"@type": "ListItem",
"position": 3,
"name": "Sulfates",
"item": "https://questionsmedicales.fr/mesh/D013431"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thiosulfates",
"item": "https://questionsmedicales.fr/mesh/D013885"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thiosulfates - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thiosulfates",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thiosulfates",
"description": "Comment diagnostiquer une intoxication aux thiosulfates ?\nQuels tests sont utilisés pour évaluer les thiosulfates ?\nQuels symptômes indiquent une intoxication aux thiosulfates ?\nY a-t-il des marqueurs biologiques pour les thiosulfates ?\nComment différencier les thiosulfates d'autres composés ?",
"url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Case-Control+Studies#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thiosulfates",
"description": "Quels sont les symptômes courants d'une intoxication ?\nLes thiosulfates provoquent-ils des effets secondaires ?\nComment les thiosulfates affectent-ils le système respiratoire ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nLes thiosulfates affectent-ils le système digestif ?",
"url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Case-Control+Studies#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thiosulfates",
"description": "Comment prévenir une intoxication aux thiosulfates ?\nY a-t-il des mesures de sécurité en milieu professionnel ?\nLes thiosulfates peuvent-ils être évités dans certains aliments ?\nQuelles sont les recommandations pour les travailleurs exposés ?\nLes thiosulfates sont-ils réglementés ?",
"url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Case-Control+Studies#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thiosulfates",
"description": "Quel est le traitement principal pour l'intoxication aux thiosulfates ?\nLes thiosulfates sont-ils utilisés en médecine préventive ?\nY a-t-il des antidotes pour les thiosulfates ?\nComment administrer les thiosulfates en cas d'urgence ?\nLes thiosulfates sont-ils efficaces contre toutes les intoxications ?",
"url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Case-Control+Studies#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thiosulfates",
"description": "Quelles complications peuvent survenir après une intoxication ?\nLes thiosulfates peuvent-ils causer des dommages permanents ?\nY a-t-il des risques de rechute après traitement ?\nComment surveiller les complications post-intoxication ?\nLes complications sont-elles prévisibles ?",
"url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Case-Control+Studies#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thiosulfates",
"description": "Quels sont les facteurs de risque d'intoxication aux thiosulfates ?\nLes enfants sont-ils plus à risque d'intoxication ?\nY a-t-il des conditions médicales qui augmentent le risque ?\nLes personnes âgées sont-elles plus à risque ?\nComment évaluer le risque d'exposition aux thiosulfates ?",
"url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Case-Control+Studies#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux thiosulfates ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et des tests sanguins pour mesurer les niveaux de thiosulfate."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les thiosulfates ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter les thiosulfates."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aux thiosulfates ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour les thiosulfates ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de thiosulfate dans le sang peuvent indiquer une intoxication."
}
},
{
"@type": "Question",
"name": "Comment différencier les thiosulfates d'autres composés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests chimiques spécifiques peuvent identifier les thiosulfates parmi d'autres composés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une intoxication ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées, et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les thiosulfates provoquent-ils des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des démangeaisons ou des éruptions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les thiosulfates affectent-ils le système respiratoire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des difficultés respiratoires en cas d'intoxication sévère."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les enfants ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes plus graves, comme des convulsions."
}
},
{
"@type": "Question",
"name": "Les thiosulfates affectent-ils le système digestif ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer des nausées, des vomissements et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment prévenir une intoxication aux thiosulfates ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez l'exposition à des sources connues de thiosulfates et suivez les consignes de sécurité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures de sécurité en milieu professionnel ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des équipements de protection individuelle doivent être utilisés lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Les thiosulfates peuvent-ils être évités dans certains aliments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains aliments peuvent contenir des thiosulfates; il est conseillé de les limiter si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les travailleurs exposés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des formations sur les risques et l'utilisation d'équipements de protection sont essentielles."
}
},
{
"@type": "Question",
"name": "Les thiosulfates sont-ils réglementés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est souvent réglementée pour minimiser les risques d'intoxication."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'intoxication aux thiosulfates ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste en l'administration de thiosulfate de sodium par voie intraveineuse."
}
},
{
"@type": "Question",
"name": "Les thiosulfates sont-ils utilisés en médecine préventive ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés pour prévenir les effets de certaines intoxications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des antidotes pour les thiosulfates ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le thiosulfate de sodium est souvent utilisé comme antidote pour les intoxications au cyanure."
}
},
{
"@type": "Question",
"name": "Comment administrer les thiosulfates en cas d'urgence ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils doivent être administrés par un professionnel de santé, généralement par voie intraveineuse."
}
},
{
"@type": "Question",
"name": "Les thiosulfates sont-ils efficaces contre toutes les intoxications ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité est spécifique à certaines intoxications, comme celle au cyanure."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une intoxication ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques et respiratoires peuvent survenir si non traitées."
}
},
{
"@type": "Question",
"name": "Les thiosulfates peuvent-ils causer des dommages permanents ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une intoxication sévère peut entraîner des dommages neurologiques permanents."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de rechute après traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des rechutes peuvent se produire si l'exposition aux thiosulfates se poursuit."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications post-intoxication ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est nécessaire pour détecter d'éventuelles complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles en fonction de la gravité de l'intoxication."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'intoxication aux thiosulfates ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et ceux manipulant des produits contenant des thiosulfates sont à risque."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque d'intoxication ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables en raison de leur taille et de leur métabolisme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conditions médicales qui augmentent le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions, comme les maladies respiratoires, peuvent augmenter le risque d'intoxication."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un métabolisme plus lent, augmentant le risque d'intoxication."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque d'exposition aux thiosulfates ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation des conditions de travail et des habitudes de vie peut aider à évaluer le risque."
}
}
]
}
]
}
Department of Civil and Environmental Engineering, Chinese National Engineering Research Center for Control & Treatment of Heavy Metal Pollution (Hong Kong Branch) and Water Technology Center, The Hong Kong University of Science and Technology, Hong Kong SAR, China.
University of Groningen, Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, Groningen, the Netherlands; University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.
School of Environmental Science and Engineering, Huazhong University of Science and Technology (HUST), Hubei Key Laboratory of Multi-media Pollution Cooperative Control in Yangtze Basin, Wuhan 430074, China.
School of Environmental Science and Engineering, Huazhong University of Science and Technology (HUST), Hubei Key Laboratory of Multi-media Pollution Cooperative Control in Yangtze Basin, Wuhan 430074, China.
College of Chemistry and Environmental Engineering, Chongqing University of Arts and Sciences, Chongqing Key Laboratory for Resource Utilization of Heavy Metal Wastewater, Yongchuan 402160, China.
School of Environmental Science and Engineering, Huazhong University of Science and Technology (HUST), Hubei Key Laboratory of Multi-media Pollution Cooperative Control in Yangtze Basin, Wuhan 430074, China.
School of Environmental Science and Engineering, Huazhong University of Science and Technology (HUST), Hubei Key Laboratory of Multi-media Pollution Cooperative Control in Yangtze Basin, Wuhan 430074, China.
School of Environmental Science and Engineering, Huazhong University of Science and Technology (HUST), Hubei Key Laboratory of Multi-media Pollution Cooperative Control in Yangtze Basin, Wuhan 430074, China.
Department of Civil & Environmental Engineering and Hong Kong Branch of the Chinese National Engineering Research Center for Control & Treatment of Heavy Metal Pollution, The Hong Kong University of Science and Technology, Hong Kong, China.
School of Environmental Science and Engineering, Huazhong University of Science and Technology (HUST), Hubei Key Laboratory of Multi-media Pollution Cooperative Control in Yangtze Basin, Wuhan 430074, China. Electronic address: ceguogang@hust.edu.cn.
Infections caused by antimicrobial-resistant bacteria are a significant cause of death worldwide, and carbapenemase-producing bacteria are the principal agents. New Delhi metallo-beta-lactamase-1 prod...
A retrospective case-control study with patients hospitalized from January 2012 to February 2018 at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" was designed. During this period, 139 patie...
One hundred and thirty-nine case patients with a KP-NDM-1 isolate and 486 control patients were analyzed. In the case group, acute renal failure was a significant comorbidity, hospitalization days wer...
In this study, the previous use of antibiotics, the use of a urinary catheter, the use of a central venous catheter, the use of mechanical ventilation, and ICU stay were shown to be predictors of infe...
While errors can harm patients they remain poorly studied. This study characterized errors in the care of surgical patients and examined the association of errors with morbidity and mortality....
Errors have been reported to cause <10% or >60% of adverse events. Such discordant results underscore the need for further exploration of the relationship between error and adverse events....
Patients with operations performed at a single institution and abstracted into the American College of Surgeons National Surgical Quality Improvement Program from January 1, 2018, to December 31, 2018...
Of 1899 patients, 170 were defined as cases who experienced a morbidity or mortality. The majority of cases (n=93; 55%) had at least 1 error; of the 329 matched control patients, 112 had at least 1 er...
Errors in surgical care were associated with postoperative morbidity. Reducing errors requires measurement of errors....
Iron deficiency is a common problem in subfertile women. The influence of iron status on unexplained infertility is unknown....
In a case-control study, 36 women with unexplained infertility and 36 healthy non-infertile controls were included. Parameters of iron status including serum ferritin and a serum ferritin <30 µg/dL se...
Women with unexplained infertility demonstrated a lower transferrin saturation (median 17.3%, IQR 12.7-25.2 versus 23.9%, IQR 15.4-31.6;...
Ferritin levels <30µg/L were associated with unexplained infertility and might be screened in the future. Further studies with a focus on iron deficiency and iron treatment on women with unexplained i...
There are few studies published referring to bariatric surgery in patients older than 70 years. The aim of this study is to evaluate whether there are benefits to performing sleeve gastrectomy (SG) in...
Data were retrospectively collected from a Private Clinic's electronic medical records of patients undergoing SG between June 2017 and September 2020. Inclusion criteria were patients older than 70 ye...
Fifty patients were included in the study. Both groups were similar regarding gender, weight, BMI, and presence of DM. The 30-day morbidity and mortality were similar between the groups. The patients ...
The sleeve gastrectomy surgery performed in patients over 70 years of age is safe. The early results suggest similar benefits regarding weight loss and improvement of comorbidities to those having SG ...
The etiology of diverticulitis is multifactorial and poorly understood. We estimated the familiality of diverticulitis using the Utah Population Database, a statewide database linking medical records ...
We identified patients with diverticulitis diagnosed between 1998 and 2018 and age- and sex-matched controls in the Utah Population Database. Risk of diverticulitis in family members of patients and c...
The study population included 9,563 diverticulitis patients (with 229,647 relatives) and 10,588 controls (with 265,693 relatives). Relatives of patients were more likely to develop diverticulitis (inc...
Our results indicate that the first-, second-, and third-degree relatives of diverticulitis patients are at elevated risk of developing diverticulitis. This information may aid surgeons in counseling ...
This study aimed to investigate the clinical and laboratory as well as radiological features of spondyloarthritis (SpA) patients with thrombocytosis and to explore risk factor for thrombocytosis in Sp...
A total of 145 patients with SpA were included in this study, and non-thrombocytosis was identified in 76 patients while thrombocytosis was found in 69 patients, 38 out of the 69 patients received ant...
The proportion of hip involvement (60.86% vs 36.84%, p = 0.004), bath ankylosing spondylitis disease activity index score (4.24 ± 0.55 vs 3.69 ± 0.67, p < 0.001), erythrocyte sedimentation rate (62.22...
SpA patients with thrombocytosis have a higher proportion of hip involvement and disease activity compared to non-thrombocytosis SpA patients. The potential risk factors for thrombocytosis in SPA pati...
Recent studies of the vaginal microbiome have led to a better understanding of the microbiota and interactions with the host environment, however the role of the vaginal microbiome in vestibulodynia r...
This study aims to investigate and examine differences in the bacterial and fungal microbiome among patients with vestibulodynia and healthy controls....
A case-control study was conducted examining the vaginal microbiome of 29 patients with vestibulodynia and 26 controls through Stony Brook University Obstetrics and Gynecology ambulatory clinic. Exclu...
Principal component analysis (PCA) and linear discriminant analysis effect size (LefSe) were used to identify differences in relative abundance of operational taxonomic units (OTUs) for the vaginal mi...
Lactobacillus species were dominant amongst both cases and controls. PCA of 16S and ITS OTUs did not show significant differences in microbiome composition between vestibulodynia patients and controls...
Additional studies are needed to further assess the clinical significance of these findings....
Strengths of this study include ITS amplicon sequence analysis for fungal species diversity. Limitations of this study include small sample size and lack of racial diversity....
Our study did not find significant differences in composition or diversity between the vaginal microbiomes of cases of vestibulodynia and controls; however, the data suggests differences in abundance ...
Varied reports suggest a contentious relationship of bladder malignancy with pioglitazone in patients with type 2 diabetes....
To study an association (prevalence and predictors) of bladder malignancy with pioglitazone therapy in Asian-Indian type 2 diabetes patients....
In this observational multicenter study, type 2 diabetic patients attending out-patient diabetes-clinic were evaluated. A detailed history of anti-diabetic medication, dose, duration, pioglitazone usa...
A total of 8000 patients were screened out of which 1560 were excluded. Among 6440 included patients, 1056 (16.3%) patients were in group A and 5384 (83.6%) group B. Patients on pioglitazone were olde...
Pioglitazone use in Asian-Indians is not associated with an increased bladder cancer risk. However, pioglitazone should be restricted in individuals with history of hematuria. Age more than 58 years i...
Multiple chemical sensitivity (MCS) is a chronic condition characterized by the appearance of symptoms caused by exposure to chemical compounds that are tolerable for the general population. It mainly...
Stroke is the leading cause of mortality in China. DNA methylation has essential roles in multiple diseases, but its association with stroke was barely studied. We hereby explored the association betw...
The association was discovered in a hospital-based case-control study (cases/controls = 190:190) and further validated in a prospective nested case-control study including 139 cases who developed stro...
In our study, altered HTRA1 methylation was associated with stroke at clinical and preclinical stages and thus may provide a potential biomarker in the blood for the risk evaluation and preclinical de...